PRB-001

N/A

Report date: 2025/01/26 16:46:34
NME

Base Information

Drug NamePRB-001
Drug Alias NamePRB-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEGFR exon 20 insertion mutations inhibitors
TargetsEGFR exon 20 insertion mutationsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPearlRiver Bio GmbH
China Registration ClassN/A

Develop Information

Active CompaniesLead Discovery Center GmbHPearlRiver Bio GmbHUniversity Of Cologne
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A